share_log

Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335

Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335

Leerink Partners将Shockwave Medical的评级下调至市场表现,将目标股价下调至335美元
Moomoo 24/7 ·  04/08 14:24

Leerink Partners analyst Mike Kratky downgrades Shockwave Medical (NASDAQ:SWAV) from Outperform to Market Perform and lowers the price target from $361 to $335.

Leerink Partners分析师迈克·克拉特基将Shockwave Medical(纳斯达克股票代码:SWAV)的评级从跑赢大盘下调至市场表现,并将目标股价从361美元下调至335美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发